On 15 January 2015, orphan designation (EU/3/14/1414) was granted by the European Commission to Hope Pharmaceuticals, Ltd, United Kingdom, for sodium thiosulfate for the treatment of calciphylaxis.
The sponsor’s address was updated in March 2019.
|Disease / condition||
Treatment for calciphylaxis
|Date of decision||
|Orphan decision number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;